BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 31030748)

  • 1. Ganoderma lucidum polysaccharide used for treating physical frailty in China.
    Zeng P; Chen Y; Zhang L; Xing M
    Prog Mol Biol Transl Sci; 2019; 163():179-219. PubMed ID: 31030748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical, biochemical, preclinical and clinical studies of Ganoderma lucidum polysaccharide as an approved drug for treating myopathy and other diseases in China.
    Zeng P; Guo Z; Zeng X; Hao C; Zhang Y; Zhang M; Liu Y; Li H; Li J; Zhang L
    J Cell Mol Med; 2018 Jul; 22(7):3278-3297. PubMed ID: 29691994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganoderma sinense polysaccharide: An adjunctive drug used for cancer treatment.
    Zhang Y; Jiang Y; Zhang M; Zhang L
    Prog Mol Biol Transl Sci; 2019; 163():165-177. PubMed ID: 31030747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities.
    Xu Z; Chen X; Zhong Z; Chen L; Wang Y
    Am J Chin Med; 2011; 39(1):15-27. PubMed ID: 21213395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of bioactive polysaccharides from Ganoderma lucidum (Lingzhi), a review.
    Lu J; He R; Sun P; Zhang F; Linhardt RJ; Zhang A
    Int J Biol Macromol; 2020 May; 150():765-774. PubMed ID: 32035956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of Ganoderma sinense polysaccharide-an adjunctive drug used during concurrent Chemo/Radiation therapy for cancer treatment in China.
    Jiang Y; Chang Y; Liu Y; Zhang M; Luo H; Hao C; Zeng P; Sun Y; Wang H; Zhang L
    Biomed Pharmacother; 2017 Dec; 96():865-870. PubMed ID: 29078264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pharmacological Rationales and Molecular Mechanisms of
    Luo H; Tan D; Peng B; Zhang S; Vong CT; Yang Z; Wang Y; Lin Z
    Am J Chin Med; 2022; 50(1):53-90. PubMed ID: 34963429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (Higher Basidiomycetes) polysaccharides injection formulation.
    Jiang Y; He A; Liu Y; Xie B; Li Y; Deng Y; Liu X; Liu Q
    Int J Med Mushrooms; 2014; 16(5):411-9. PubMed ID: 25271977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficacy and Toxicity of Using the Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), and Its Products in Chemotherapy (Review).
    Cizmarikova M
    Int J Med Mushrooms; 2017; 19(10):861-877. PubMed ID: 29256841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganoderma lucidum (Reishi mushroom) for cancer treatment.
    Jin X; Ruiz Beguerie J; Sze DM; Chan GC
    Cochrane Database Syst Rev; 2012 Jun; (6):CD007731. PubMed ID: 22696372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Anti-Inflammatory and Antioxidant Activities of Mycelial Polysaccharides from Different Strains of Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes).
    Zhang J; Shi X; Cheng W; Wang Q; Wang C; Li M; Zhao D; An Q
    Int J Med Mushrooms; 2022; 24(7):77-90. PubMed ID: 35993963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative assessment of the potential of polysaccharide production and intracellular sugar composition within Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (W.Curt.:Fr.)P. Karst. (Aphyllophoromycetideae).
    Stajić M; Glamoclija J; Maksimović V; Vukojević J; Simonić J; Zervakis G
    Int J Med Mushrooms; 2011; 13(2):153-8. PubMed ID: 22135891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-Promoting of Polysaccharides Extracted from
    Seweryn E; Ziała A; Gamian A
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of migration and induction of apoptosis in LoVo human colon cancer cells by polysaccharides from Ganoderma lucidum.
    Liang ZE; Yi YJ; Guo YT; Wang RC; Hu QL; Xiong XY
    Mol Med Rep; 2015 Nov; 12(5):7629-36. PubMed ID: 26397202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From 2000years of Ganoderma lucidum to recent developments in nutraceuticals.
    Bishop KS; Kao CH; Xu Y; Glucina MP; Paterson RR; Ferguson LR
    Phytochemistry; 2015 Jun; 114():56-65. PubMed ID: 25794896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum.
    Lin ZB
    J Pharmacol Sci; 2005 Oct; 99(2):144-53. PubMed ID: 16230843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganodermataceae: natural products and their related pharmacological functions.
    Zhou X; Lin J; Yin Y; Zhao J; Sun X; Tang K
    Am J Chin Med; 2007; 35(4):559-74. PubMed ID: 17708623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical optimization of polysaccharide production by submerged cultivation of Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (W.Curt.: Fr.) P. Karst. MTCC 1039 (Aphyllophoromycetideae).
    Baskar G; Sathya SR; Jinnah RB; Sahadevan R
    Int J Med Mushrooms; 2011; 13(1):41-9. PubMed ID: 22135903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms.
    Lin ZB; Zhang HN
    Acta Pharmacol Sin; 2004 Nov; 25(11):1387-95. PubMed ID: 15525457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropharmacological Effect and Clinical Applications of Ganoderma (Lingzhi).
    Cui X; Zhang Y
    Adv Exp Med Biol; 2019; 1182():143-157. PubMed ID: 31777017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.